Dose Reduction May Jeopardize Efficacy of Abiraterone Acetate

J Clin Oncol. 2018 Oct 20;36(30):3062-3064. doi: 10.1200/JCO.2018.79.3182. Epub 2018 Sep 6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Abiraterone Acetate*
  • Androstenes
  • Humans
  • Male
  • Prospective Studies
  • Prostatic Neoplasms, Castration-Resistant*

Substances

  • Androstenes
  • Abiraterone Acetate
  • abiraterone